Literature DB >> 16479576

Proteasome and transcription: a destroyer goes into construction.

Ashok N Hegde1, Sudarshan C Upadhya.   

Abstract

The proteasome is a proteolytic complex that is known to degrade proteins marked by the attachment of ubiquitin. Recently, it has become apparent that the proteasome has non-proteolytic roles. Several studies have implicated the proteasome in the regulation of transcription. A new study now shows that the proteasome facilitates the interaction of a histone acetyltransferase complex with transcriptional activators at active promoters. Copyright 2006 Wiley Periodicals, Inc.

Mesh:

Substances:

Year:  2006        PMID: 16479576     DOI: 10.1002/bies.20379

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  5 in total

Review 1.  Role of ubiquitin-proteasome-mediated proteolysis in nervous system disease.

Authors:  Ashok N Hegde; Sudarshan C Upadhya
Journal:  Biochim Biophys Acta       Date:  2010-08-03

2.  A genetic suppressor of two dominant temperature-sensitive lethal proteasome mutants of Drosophila melanogaster is itself a mutated proteasome subunit gene.

Authors:  Peter J Neuburger; Kenneth J Saville; Jue Zeng; Kerrie-Ann Smyth; John M Belote
Journal:  Genetics       Date:  2006-04-28       Impact factor: 4.562

3.  Proteasome subunits relocalize during human cytomegalovirus infection, and proteasome activity is necessary for efficient viral gene transcription.

Authors:  Karen Tran; Jeffrey A Mahr; Deborah H Spector
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

4.  A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice.

Authors:  M Wehenkel; J-O Ban; Y-K Ho; K C Carmony; J T Hong; K B Kim
Journal:  Br J Cancer       Date:  2012-06-07       Impact factor: 7.640

5.  Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.

Authors:  J van Scheppingen; D W M Broekaart; T Scholl; M R J Zuidberg; J J Anink; W G Spliet; P C van Rijen; T Czech; J A Hainfellner; M Feucht; A Mühlebner; E A van Vliet; E Aronica
Journal:  J Neuroinflammation       Date:  2016-08-26       Impact factor: 8.322

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.